The use of antimicrobials without microbiological proof is frequent and contributes to the emergence of resistance. The aim was to identify the organisms isolated during laboratory examinations and the type of antimicrobials consumed by patients hospitalized to Infectious Diseases’ Clinic. This is a cross-sectional and analytical study, carried out from January 1 to December 31, 2017 in the Infectious Diseases Department of Point “G” Teaching Hospital in Mali. All biological specimens from patients during the study period were analyzed. In total, 322 patients benefited from microbiological test, with a mean age of 40.9 ± 12.2 years (range 15 and 74 years) with a sex ratio of 0.93. Only 5.6% of patients were HIV negative. In all participants, a total of 658 microbiological specimen were taken, 224 (34.0%) identified at least one pathogen including bacteria in more than a half of the cases (58.5%). On the report of bacteriological analysis, the most frequently identified organisms were Mycobacterium tuberculosis (42.2%) mainly in sputum; Escherichia coli (24.2%) and Klebsiella pneumoniae (7.8%) commonly in urine and Gardnerella vaginalis (7.0%) exclusively in vaginal secretions. Candida albicans (5/8) and Cryptococcus neoformans (3/8) were the most common fungi while Plasmodium falciparum (96.4%) represented the parasite frequently found in blood. From a therapeutic standpoint, 1143 antimicrobials were prescribed to 322 admitted patients, i.e. 3.55 anti-infectives per patient. Antibiotics (excluding tuberculosis drugs), antiparasitics and antifungals represented respectively 46.2%; 18.8% and 15.1% of anti-infectives. Antibiotic therapy was effective in 274 (85.1%) patients and among them, only 76 (27.7%) cases were based on microbiological evidence. Antibiotics are the most widely used antimicrobials in an infectious disease department. Empiric treatments are common but must be minimized by the search for microbiological evidence.
Jie, Y., Liang, X. and Li, Z. (2013) The Antibacterial Drug Discovery. In: El-Shemy, H., Ed., Drug Discovery, IntechOpen Limited, London, 289-307. https://doi.org/10.5772/52510
Davies, J. and Davies, D. (2010) Origins and Evolution of Antibiotic Resistance. Microbiology and Molecular Biology Reviews, 74, 417-433. https://doi.org/10.1128/MMBR.00016-10
Ndihokubwayo, J.B., Yahaya, A.A., Desta, A.T., Ki-Zerbo, G., Odei, E.A., Keita, B., et al. (2013) Antimicrobial Resistance in the African Region: Issues, Challenges and Actions Proposed. World Health Organization, Regional Office for Africa.
Kouegnigan Rerambiah, L., Ndong, J.-C., Mbakob Mengue Massoua, P., Medzegue, S., Elisee-Ndam, M., Mintsa-Ndong, A., et al. (2014) Antimicrobial Profiles of Bacterial Clinical Isolates from the Gabonese National Laboratory of Public Health: Data from Routine Activity. International Journal of Infectious Diseases, 29, 48-53. https://doi.org/10.1016/j.ijid.2014.01.015
World Health Organization (2014) Antimicrobial Resistance: Global Report on Surveillance. World Health Organization, Geneva. https://apps.who.int/iris/handle/10665/112642
Founou, R.C., Founou, L.L. and Essack, S.Y. (2017) Clinical and Economic Impact of Antibiotic Resistance in Developing Countries: A Systematic Review and Meta-Analysis. PLoS ONE, 12, e0189621. https://doi.org/10.1371/journal.pone.0189621
Vodovar, D., Marcadé, G., Raskine, L., Malissin, I. and Mégarbane, B. (2013) Entérobactéries productrices de bêta-lactamases à spectre élargi: Epidémiologie, facteurs de risque et mesures de prévention. La Revue de Médecine Interne, 34, 687-693. https://doi.org/10.1016/j.revmed.2012.10.365
Lambrini, K. (2017) The Rational Use of Antibiotics Medicine. Journal of Health Communication, 2, 36. https://doi.org/10.4172/2472-1654.100067
O’Neill, J. (2016) Tackling Drug-Resistant Infections Globally: Final Report and Recommendations May. Review on Antimicrobian Resistance. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf
Versporten, A., Zarb, P., Caniaux, I., Gros, M.-F., Drapier, N., Miller, M., et al. (2018) Antimicrobial Consumption and Resistance in Adult Hospital Inpatients in 53 Countries: Results of an Internet-Based Global Point Prevalence Survey. Lancet Global Health, 6, e619-e629. https://doi.org/10.1016/S2214-109X(18)30186-4
Dia, M.L., Chabouny, H. and Diagne, R. (2015) Profil antibiotypique des bactéries uropathogènes isolées au CHU de Dakar. Uro’Andro, 1, 212-217.
Lo, S., Ka, R., Ba-Diallo, A., Diallo, O., Diagne, R., Dia, M.L., et al. (2014) Sensibilité aux antibiotiques des Entérobactéries isolées d’urines au Centre Hospitalier Régional de Saint Louis (Sénégal) de juin 2011 à juillet 2012. Rev CAMES SANTE, 2, 25-28.
Ouedraogo, A.S., Pierre, H.J., Bañuls, A.L., Ouédraogo, R. and Godreuil, S. (2017) Emergence and Spread of Antibiotic Resistance in West Africa: Contributing Factors and Threat Assessment. Médecine et Santé Tropicales, 27, 147-154. https://doi.org/10.1684/mst.2017.0678
Hailaji, N.S.M., Ould Salem, M.L. and Ghaber, S.M. (2016) La sensibilité aux antibiotiques des bactéries uropathogènes dans la ville de Nouakchott-Mauritanie. Progrès en Urologie, 26, 346-352. https://doi.org/10.1016/j.purol.2016.04.004
Prah, J., Kizzie-Hayford, J., Walker, E. and Ampofo-Asiama, A. (2017) Antibiotic Prescription Pattern in a Ghanaian Primary Health Care Facility. Pan African Medical Journal, 28, Article No. 214. https://doi.org/10.11604/pamj.2017.28.214.13940
Randriatsarafara, F.M., Ralamboson, J., Rakotoarivelo, R., Raherinandrasana, A. and Andrianasolo, R. (2015) Consommation d’antibiotiques au Centre Hospitalier Universitaire d’Antananarivo: Prévalence et défis stratégiques. Santé Publique, 27, 249-255. https://doi.org/10.3917/spub.152.0249
Barbosa, T.M. and Levy, S.B. (2000) The Impact of Antibiotic Use on Resistance Development and Persistence. Drug Resistance Updates, 3, 303-311. https://doi.org/10.1054/drup.2000.0167
Guidos, R. (2011) Combating Antimicrobial Resistance: Policy Recommendations to Save Lives. Clinical Infectious Diseases, 52, S397-S428. https://doi.org/10.1093/cid/cir153
Cosgrove, S.E. (2006) The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs. Clinical Infectious Diseases, 42, S82-S89. https://doi.org/10.1086/499406
Monnet, D.L., López-Lozano, J.-M., Campillos, P., Burgos, A., Yagüe, A. and Gonzalo, N. (2001) Making Sense of Antimicrobial Use and Resistance Surveillance Data: Application of ARIMA and Transfer Function Models. Clinical Microbiology and Infection, 7, 29-36. https://doi.org/10.1046/j.1469-0691.2001.00071.x
Cavalié, P. and Hider-Mlynarz, K. (2017) L’évolution des consommations d’antibiotiques en France entre 2000 et 2015. Agence nationale de sécurité du médicament et des produits de santé, France.
World Health Organization (1985) The Rational Use of Drugs. Report of the Conference of Experts. World Health Organization, Geneva. http://www.apps.who.int/medicinedocs/en/m/abstract/Js17054e/
Ghana National Drugs Programme (GNDP) (2010) Standard Treatment Guidelines. 6th Edition, Ministry of Health, Ghana, Greater Accra.
Federal Ministry of Health, World Health Organization (2016) Standard Treatment Guidelines. 2nd Edition, Federal Ministry of Health, World Health Organization, Nigeria, 116 p. https://www.medbox.org/document/nigeria-standard-treatment-guidelines#GO
Coulibaly, Y., Konaté, A., Koné, D. and Bougoudogo, F. (2014) étude de la prescription des antibiotiques en milieu hospitalier malien. Revue Malienne d’Infectiologie et de Microbiologie, 3, 2-8.
Société Française de Microbiologie (2019) Comité de l’antibiogramme de la Société Française de Microbiologie. Recommandations 2019 V.1.0 Janvier. 2019 éd, CASFM / EUCAST: Société Française de Microbiologie, France, 144 p. https://www.sfm-microbiologie.org/2019/01/07/casfm-eucast-2019/
Elbouti, A., Rafai, M., Chouaib, N., Jidane, S., Belkouch, A., Bakkali, H., et al. (2016) Evaluation des prescriptions antibiotiques au service des urgences de l’Hôpital Militaire d’Instruction Mohammed V (HMIMV). Pan African Medical Journal, 25, Article No. 162. https://doi.org/10.11604/pamj.2016.25.162.7080 http://www.panafrican-med-journal.com/content/article/25/162/full/
Anand Paramadhas, B.D., Tiroyakgosi, C., Mpinda-Joseph, P., Morokotso, M., Matome, M., Sinkala, F., et al. (2019) Point Prevalence Study of Antimicrobial Use among Hospitals across Botswana; Findings and Implications. Expert Review of Anti-Infective Therapy, 17, 535-546. https://doi.org/10.1080/14787210.2019.1629288
Bowen, L.N., Smith, B., Reich, D., Quezado, M. and Nath, A. (2016) HIV-Associated Opportunistic CNS Infections: Pathophysiology, Diagnosis and Treatment. Nature Reviews Neurology, 12, 662-674. https://doi.org/10.1038/nrneurol.2016.149
Kaboré, M., Konaté, I., Sondo, K.A., Mohamed, M.N., Cissé, M.A., Zaré, A., et al. (2018) Profil épidémiologique, clinique et évolutif de la co-infection tuberculose et VIH dans le service de maladies infectieuses de l’hôpital national du Point > (Mali). Revue de Pneumologie Tropicale, 29, 25-30.
Mjid, M., Cherif, J., Ben Salah, N., Toujani, S., Ouahchi, Y., Zakhama, H., et al. (2015) épidémiologie de la tuberculose. Revue de Pneumologie Clinique, 71, 67-72. https://doi.org/10.1016/j.pneumo.2014.04.002
Toner, L., Papa, N., Aliyu, S.H., Dev, H., Lawrentschuk, N. and Al-Hayek, S. (2016) Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in Hospital Urinary Tract Infections: Incidence and Antibiotic Susceptibility Profile over 9 Years. World Journal of Urology, 34, 1031-1037. https://doi.org/10.1007/s00345-015-1718-x
Vora, S. and Auckenthaler, R. (2009) Que signifie “beta-lactamases à spectre élargi” en pratique? Revue Médicale Suisse, 5, 1991-1994.
Shoai Tehrani, M., Charlier-Woerther, C. and Lortholary, O. (2014) Cryptococcose. EMC—Maladies Infectieuses, 11, 8-613-A-10.
Coulibaly, D., Travassos, M.A., Kone, A.K., Tolo, Y., Laurens, M.B., Traore, K., et al. (2014) Stable Malaria Incidence despite Scaling up Control Strategies in a Malaria Vaccine-Testing Site in Mali. Malaria Journal, 13, Article No. 374. https://doi.org/10.1186/1475-2875-13-374
Grappin, M., Chavanet, P. and Portier, H. (2007) Bêtalactamines. EMC—Traité de médecine AKOS, 10, 1-8.